The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study

The below article reinforces the importance of contributions to the regulatory process and highlights the added value that is brought by people living with conditions as patients, carers, parents or even as patient representatives.

Click here to read the article from the European Medicines Agency.

Newsletter Signup

To keep up to date with our news and activities,
please leave your details below

GDPR Compliance Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.